SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. Ferreira IATM, Kemp SA, Datir R, Saito A, et al. J Infect Dis 2021;224:989-994.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ferreira IATM, Kemp SA, Datir R, Saito A, et al. SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion. J Infect Dis 2021;224:989-994.
PMID: 34260717